The NLRP3 inflammasome and diabetic cardiomyopathy : editorial to: "Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model" by Beibei Luo et al

Cardiovasc Drugs Ther. 2014 Feb;28(1):5-6. doi: 10.1007/s10557-013-6501-x.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Carrier Proteins
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Cardiomyopathies / drug therapy*
  • Fluorobenzenes / pharmacology*
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Pyrimidines / pharmacology*
  • Receptors, Cytoplasmic and Nuclear / genetics*
  • Rosuvastatin Calcium
  • Sulfonamides / pharmacology*

Substances

  • Carrier Proteins
  • Fluorobenzenes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, rat
  • Pyrimidines
  • Receptors, Cytoplasmic and Nuclear
  • Sulfonamides
  • Rosuvastatin Calcium